We hypothesize that GC TIL-B in HPV+ HNSCC may be more equipped to present antigen to CD4+ T cells given their presence in TLS with GC and expression of CD40, CD86, and ICAM1, which are key proteins involved in interactions with TFH cells. The gene discussed is CD86; the disease is head and neck squamous cell carcinoma.